Patents Assigned to LIfT Biosciences Ltd
  • Cancer-killing cells
    Patent number: 11878033
    Abstract: The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: January 23, 2024
    Assignee: LIFT BIOSCIENCES LTD
    Inventors: Alex Blyth, Nico Bruyniks
  • CANCER-KILLING CELLS
    Publication number: 20230346834
    Abstract: The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
    Type: Application
    Filed: March 24, 2023
    Publication date: November 2, 2023
    Applicant: LIfT BioSciences Ltd
    Inventors: Alex Blyth, Nico Bruyniks
  • Cancer-killing cells
    Patent number: 11642373
    Abstract: The present invention relates to an in vitro culture of haematopoietic cells, wherein said haematopoietic cells differentiate to form granulocytes characterised by the ability to kill cancer cells. The invention also relates to said granulocytes, methods for identifying said haematopoietic cells and granulocytes, compositions and kits comprising the same, as well as uses of the same for treating cancer.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: May 9, 2023
    Assignee: LIfT Biosciences Ltd
    Inventors: Alex Blyth, Nico Bruyniks